Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type.
about
Enhanced interleukin-4 production in CD4+ T cells and elevated immunoglobulin E levels in antigen-primed mice by bisphenol A and nonylphenol, endocrine disruptors: involvement of nuclear factor-AT and Ca2+Efficient presentation of house dust mite allergen Der p 2 by monocyte-derived dendritic cells and the role of beta 2 integrins.Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy.Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature.Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.Does atopic disease start in foetal life?Mechanisms of allergen-specific immunotherapy.Interleukin-4 and interleukin-13: their similarities and discrepancies.Is Th1 the solution for Th2 in asthma?Various types of Dirofilaria immitis polyproteins selectively induce a Th2-Type immune responseType 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases.Actual therapeutic management of allergic and hyperreactive nasal disordersCD4+ T-helper-cell responses in mice with low-level Candida albicans infection.Regulation of parasite antigen-driven immune responses by interleukin-10 (IL-10) and IL-12 in lymphatic filariasis.CD81 on B cells promotes interleukin 4 secretion and antibody production during T helper type 2 immune responsesThe effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic modelNovel genetic regulation of T helper 1 (Th1)/Th2 cytokine production and encephalitogenicity in inbred mouse strainsLow dose Leishmania major promotes a transient T helper cell type 2 response that is down-regulated by interferon gamma-producing CD8+ T cellsDissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.Role of interleukin 10 in specific immunotherapy.Differential effects of staphylococcal toxic shock syndrome toxin-1 on B cell apoptosis.Immunotherapy in asthma.Factors influencing the allergenicity and adjuvanticity of allergens.Cytokine pathways in allergic disease.Immunoregulation in human lymphatic filariasis: the role of interleukin 10.Hypoallergenic derivatives of major grass pollen allergens for allergy vaccination.Nasal challenges with recombinant derivatives of the major birch pollen allergen Bet v 1 induce fewer symptoms and lower mediator release than rBet v 1 wild-type in patients with allergic rhinitis.Differential regulation of Th1 and Th2 cells by p91-110 and p21-40 peptides of the 16-kD alpha-crystallin antigen of Mycobacterium tuberculosis.Effects of anti-IL-4 receptor monoclonal antibody on in vitro T cell cytokine levels: IL-4 production by T cells from non-atopic donors.Immune deviation--the third dimension of nondeletional T cell tolerance.Interleukin 4 content in chronic lymphocytic leukaemia (CLL) B cells and blood CD8+ T cells from B-CLL patients: impact on clonal B-cell apoptosis.Amelioration of ovalbumin-induced allergic airway disease following Der p 1 peptide immunotherapy is not associated with induction of IL-35.Wasp venom immunotherapy induces a shift from IL-4-producing towards interferon-gamma-producing CD4+ and CD8+ T lymphocytes.Administration of polysaccharides from Antrodia camphorata modulates dendritic cell function and alleviates allergen-induced T helper type 2 responses in a mouse model of asthma.The modulatory effects of lipopolysaccharide-stimulated B cells on differential T-cell polarization.Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.T cell proliferation and cytokine responses to ovalbumin and ovomucoid detected in children with and without egg allergy.Wasp venom immunotherapy changes IgG antibody specificity.Coimmunization of MHC class II competitor peptides during experimental autoimmune myasthenia gravis induction resulted not only in a suppressed, but also in an altered immune response.
P2860
Q28395085-FDBA72C9-9A69-4C6E-8060-627249BC8CAFQ30303586-E07A8086-BB0C-4D9D-8285-D8C54D7BF652Q30442832-8106FFA7-0AEF-4AE3-A8F8-6253364FB7F5Q31891476-0F861E32-B11A-4C49-A1FE-1360BDC9D49DQ33204109-DA9CF98B-DFE8-4593-AD44-3B531237EEF0Q33737248-4599DC5A-9CF1-4D4F-BE4A-CD35E3553066Q33851520-E76056BE-ED78-4ADC-8222-5B737F41144AQ33945896-42C77EA9-2D70-428F-AC41-413D955CA1A0Q34488885-47673EA2-29E8-4DBE-BE0D-F380E926CE13Q34632441-DA4CD9C0-9DA5-4924-AF32-DA1363EF073AQ35106276-FB9C68E9-E1FF-487A-B389-81A1270EFE4DQ35372676-55C7A30D-7FAC-4142-A086-64D4C2A6913AQ35427205-821D5391-CB29-4329-947B-38CD62DF22B3Q35530617-DF06F0A0-9330-4F14-9A12-1AA1500C1FAFQ35546559-167A030A-2228-4617-A6E3-B24FB393671AQ35921103-68ACF2A7-56C5-4E45-BE2E-7FCADE20DC78Q36365507-24D89391-2DBB-4670-B682-045B64A5BC3DQ36376497-C186D67D-87B5-4BAC-9EF5-949F2C5D7283Q36399080-ECBF82E0-999C-4A79-94D6-52377142FC55Q36798594-6D4953BD-9996-4626-8C3B-065CF54F1888Q37387064-5AD17BCF-54DA-4959-B36C-607DE35671BBQ37588015-E342B9B1-D2FF-47C0-BD9C-1232FD94C79EQ37793242-D24A11C1-6A42-4B0D-8245-D588E7A87AD0Q37900649-1343CF51-714A-450A-B1F7-D6D8F386AADDQ37981059-FC37FC11-1614-43AA-AB37-B647E118FB6BQ40383099-97344957-A646-4B8D-BC8B-0D396F014AFDQ40567247-C33E4A22-0322-48EC-A9D9-96A02CF5487BQ40628222-6B954052-02CF-4CBB-AFE7-C4B71F966940Q40989834-669ED71F-651D-4205-9443-53AED63689ACQ41008990-D3E29B10-9912-44E7-9A58-AB6A0E30EE43Q41326897-BB674921-DD12-4638-9529-5BBD02BB06ADQ43548679-2F448D1A-30DA-4497-AAEC-620DFC0C2697Q43615876-DDA56C56-D617-4680-AB7B-8FD4293906BCQ43650600-6ACC6CFF-D49B-4FC6-B5EC-7959F8478DF3Q46117238-93D57615-216A-4DC3-99D5-EB52207EBB88Q46691118-D970C4C2-59AD-4B9A-974F-B157A63843B8Q46961926-800D3EB2-864E-4B84-BB16-2AE07AFEDC16Q46990373-E674872B-D505-486E-9081-FF762046374BQ47788110-DC755B53-F8E2-48DE-9D93-9E000AFC63F4Q47826874-72C2B5C5-FE93-4E9F-B224-EF779A7C72E1
P2860
Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh
1995年學術文章
@zh-hant
name
Interleukin 4 production by CD ...... antigen-presenting cell type.
@ast
Interleukin 4 production by CD ...... antigen-presenting cell type.
@en
type
label
Interleukin 4 production by CD ...... antigen-presenting cell type.
@ast
Interleukin 4 production by CD ...... antigen-presenting cell type.
@en
prefLabel
Interleukin 4 production by CD ...... antigen-presenting cell type.
@ast
Interleukin 4 production by CD ...... antigen-presenting cell type.
@en
P2093
P2860
P356
P1476
Interleukin 4 production by CD ...... antigen-presenting cell type.
@en
P2093
D T Umetsu
R H DeKruyff
P2860
P304
P356
10.1084/JEM.181.3.1081
P407
P577
1995-03-01T00:00:00Z